Small Business

Shree Ashtavinayak shrugs off Q3 net growth, ends weak

Shree Ashtavinayak ended at Rs 84, lower by Rs 1 or 1.3%, on the BSE. - Crompton Greaves jumps on bonus issue - Max India zooms on fund raising plans - Aban Offshore slumps 8% on sharp drop in net - Cummins rallies 2% on healthy payout plans - Ashtavinayak lines up Rs 457-cr expansion - Bombay Dyeing: Banking on realty ">Bombay Dyeing: Banking on realty The stock had opened at Rs 85, and touched a high of Rs 93 and a low of Rs 83 during the day. The counter saw trades of 26.03 lakh shares as against the two-week average of 7.84 lakh shares. ---------------------------------------------------------------------------------------------------------------------(Updated at 1142am) Shree Ashtavinayak Cine Vision has jumped 7% to Rs 91.25, after the company posted 194% jump in net profit to Rs 18.29 crore in Q3FY10 when compared to Rs 6.22 crore in Q3FY09. Total operating income has appreciated by 93% to Rs 160.80 crore (Rs 83.13 crore) during the quarter. The company is engaged in in-house film production and distribution and outside film distribution. It had declared bonus shares in the ratio of 4 bonus shares for every 1 exiting fully paid up equity share held by the members on the record date fixed at February 2, 2010.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Heavy metal
India-specific hatchbacks took centrestage at the 10th AUTO EXPO, currently on in New Delhi. But BIJOY KUMAR Y took a detour and was seduced
Popular Articles

GST rates within 15 days: Dasgupta
The Goods and Services Tax (GST), the new tax regime, would have four slabs and these were likely to be unveiled within 15 days, Chairman of the Empowered Committee of State Finance Ministers Asim Dasgupta said today.

Sanofi buys Shantha in offshore deal
In another indication of Big Pharma’s growing interest in India’s drug manufacturing capabilities, French drug multinational Sanofi Aventis has announced plans to acquire Merieux Alliance’s majority stake in Hyderabad-based vaccine firm Shantha Biotechnics.